SCHEMBL30240959

SCHEMBL30240959

Nc1nc2cc(Cl)ncc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TP53 P04637 2/20 0.48
CYP3A4 P08684 2/20 0.48
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
SCN4A P35499 2/20 0.42
EPHX2 P34913 1/20 0.42
FTO Q9C0B1 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 1/20 0.42
AXL P30530 1/20 0.42
GFER P55789 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PIK3CD O00329 4/20 0.41
PIK3CG P48736 4/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CB P42338 3/20 0.41
DRD2 P14416 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19329204 1.00 ALDH1A1 (0.48) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL3711581 0.85 ALDH1A1 (0.48) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL29924638 0.85 ALDH1A1 (0.48) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL20783923 0.80 KMT2A (0.41) ALDH1A1TP53SMN1; SMN2RAB9AMAPT
SCHEMBL25604729 0.77 SMN1; SMN2 (0.55) ALDH1A1TP53SMN1; SMN2RAB9AMAPT
SCHEMBL20101093 0.77 IDO1 (0.58) ALDH1A1SMN1; SMN2RAB9AMAPTGFER
SCHEMBL9885168 0.74 SMN1; SMN2 (0.71) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL2899732 0.74 ALDH1A1 (0.59) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL29462442 0.74 ALDH1A1 (0.59) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL20101052 0.73 SMN1; SMN2 (0.58) ALDH1A1CYP3A4SMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed
WO-2025011617-A1 FUSED HETEROAROMATIC RING COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 杭州圣域生物医药科技有限公司 2025-01-16 WO disclosed
CN-109071528-B Bicyclic compounds for diagnosis and therapy AC免疫有限公司 2023-02-17 CN disclosed